产品说明书

A939572

Print
Chemical Structure| 1032229-33-6 同义名 : SCD1 Inhibitor;Stearoyl-CoA Desaturase 1 Inhibitor
CAS号 : 1032229-33-6
货号 : A132282
分子式 : C20H22ClN3O3
纯度 : 99%+
分子量 : 387.86
MDL号 : MFCD10698997
存储条件:

粉末 Sealed in dry,2-8°C

液体 -20°C:3-6个月-80°C:12个月

溶解度 :

DMSO: 105 mg/mL(270.72 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

动物实验配方:
生物活性
描述 SCD1 (stearoyl-CoA desaturase1) plays an important role in lipid metabolism and body weight control. Higher SCD1 activity in humans has been correlated with elevated plasma triglyceride levels. A939572 is an orally bioavailable and potent SCD1 inhibitor with IC50 values of <4 nM and 37 nM for mSCD1 and hSCD1, respectively [3]. A939572 demonstrated a significant dose-dependent decrease in proliferation in Caki1, A498, Caki2, and ACHN at day 5 (IC50s of 65 nM, 50 nM, 65 nM, and 6 nM respectively). Moreover, A939572 induced apoptosis in all four cell lines [4]. A939572 has modest volume of distribution and high oral bioavailability in mice (CLp= 0.4 L/h/kg; Vss= 0.4 L/kg; F= 92%). In ob/ob mice, A939572 (10 mpk bid) consistently reduced desaturation indices of all these lipid categories (cholesterol ester, diacylglycerol, free fatty acid, free cholesterol, total phospholipids, and triacylglycerol) to lean level, or even lower. A dose dependent triglyceride desaturation index reduction by A939572 was also observed in ob/ob mice [3].
实验方案
1mg 5mg 10mg

1 mM

5 mM

10 mM

2.58mL

0.52mL

0.26mL

12.89mL

2.58mL

1.29mL

25.78mL

5.16mL

2.58mL

参考文献

[1]von Roemeling CA, Marlow LA, et al. Stearoyl-CoA desaturase 1 is a novel molecular therapeutic target for clear cell renal cell carcinoma. Clin Cancer Res. 2013 May 1;19(9):2368-80.

[2]Xin Z, Zhao H, et al. Discovery of piperidine-aryl urea-based stearoyl-CoA desaturase 1 inhibitors. Bioorg Med Chem Lett. 2008 Aug 1;18(15):4298-302.

[3]Xin Z, Zhao H, Serby MD, Liu B, Liu M, Szczepankiewicz BG, Nelson LT, Smith HT, Suhar TS, Janis RS, Cao N, Camp HS, Collins CA, Sham HL, Surowy TK, Liu G. Discovery of piperidine-aryl urea-based stearoyl-CoA desaturase 1 inhibitors. Bioorg Med Chem Lett. 2008 Aug 1;18(15):4298-302. doi: 10.1016/j.bmcl.2008.06.088. Epub 2008 Jun 28. PMID: 18632269.

[4]von Roemeling CA, Marlow LA, Wei JJ, Cooper SJ, Caulfield TR, Wu K, Tan WW, Tun HW, Copland JA. Stearoyl-CoA desaturase 1 is a novel molecular therapeutic target for clear cell renal cell carcinoma. Clin Cancer Res. 2013 May 1;19(9):2368-80. doi: 10.1158/1078-0432.CCR-12-3249. Epub 2013 Apr 30. PMID: 23633458; PMCID: PMC3644999.